incidence of gastric cancer in older adult patients with chronic gastritis
DOI:
https://doi.org/10.35381/s.v.v6i2.2103Keywords:
Stomach, digestive system, microbiology. (Source, DeCS).Abstract
Objective: To develop a diagnostic study on the incidence of gastric cancer in older adult patients with chronic gastritis attended at the internal medicine service of the Hospital IESS Latacunga. Method: Clinical histories. Results: It was determined that 45% of people with gastric cancer are in stage IIA, 39% in stage IV: final, 11% in stage 0 and the remaining 5% in stage IA. Conclusion: In order to reduce the incidence levels of gastric cancer development, early detection is necessary, which is possible through health promotion and disease prevention measures, such as healthy eating habits and routine check-ups every 6 months, in people over 60 years of age, which contribute to maintain and improve people's health.
Downloads
References
Attila C, Figueroa M. Situación del cáncer gástrico en el mundo y en Chile [Situation of gastric cancer in the world and in Chile]. Revista Chilena de Cirugía. 2016; 69(6): p. 502-507.
Rodríguez F. Cáncer Gástrico: Diagnóstico y Manejo [Gastric Cancer: Diagnosis and Management]. Revista Médica de Costa Rica y Centroamérica LXXI. 2014; 339(610): p. 339 - 342.
Rollán A, Cortés P, Calvo A, Bufadel M, González R, Heredia C, et al. Diagnóstico precoz de cáncer gástrico. Propuesta de detección y seguimiento de lesiones premalignas gástricas: protocolo ACHED [Early diagnosis of gastric cancer. Proposal for detection and follow-up of gastric premalignant lesions: ACHED protocol]. Revista Médica de Chile. 2014; 142: p. 1181-1192.
Corral F, Cueva P, Yépez J, Tarupi W. Tendencias en incidencia y mortalidad por cáncer durante tres decadas en Quito - Ecuador. Colombia Médica. 2018; 49(1): p. 36-37.
Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39(7):1010428317714626. doi:10.1177/1010428317714626
Correa P. Gastric cancer: overview. Gastroenterol Clin North Am. 2013;42(2):211-217. doi:10.1016/j.gtc.2013.01.002
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635-648. doi:10.1016/S0140-6736(20)31288-5
Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700-713. doi:10.1158/1055-9965.EPI-13-1057
Petryszyn P, Chapelle N, Matysiak-Budnik T. Gastric Cancer: Where Are We Heading?. Dig Dis. 2020;38(4):280-285. doi:10.1159/000506509
Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013;107(3):230-236. doi:10.1002/jso.23262
Johnston FM, Beckman M. Updates on Management of Gastric Cancer. Curr Oncol Rep. 2019;21(8):67. Published 2019 Jun 24. doi:10.1007/s11912-019-0820-4
Tan Z. Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review. Med Sci Monit. 2019;25:3537-3541. Published 2019 May 13. doi:10.12659/MSM.916475
Camilo V, Sugiyama T, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2017;22 Suppl 1:10.1111/hel.12405. doi:10.1111/hel.12405
Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014;19 Suppl 1:1-5. doi:10.1111/hel.12165
Mentis A, Lehours P, Mégraud F. Epidemiology and Diagnosis of Helicobacter pylori infection. Helicobacter. 2015;20 Suppl 1:1-7. doi:10.1111/hel.12250
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
